Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8385 - 8392 of 12085 results

Corporate Divorce Series: Online Dating, The Bachelor, and Predicting Successful Employment Relationships
April 4, 2016| Blog| Viewpoint

The April 2016 Update -- The Mintz Matrix
April 4, 2016| Blog| Viewpoint

FDA Differentiates Biosimilar Labeling from Generic Drug Labeling
April 4, 2016| Blog| Viewpoint

Health Care Congressional Outlook for the Spring Work Period
April 4, 2016| Advisory| Viewpoint

EEOC v. Flambeau, Voluntary Plans, the Insurance Safe Harbor, and the Future of Wellness Programs
April 1, 2016| Blog| Viewpoint

Biosimilar Developments Continue at a Rapid Pace
April 1, 2016| Blog| Viewpoint

Judge Sides with AseraCare, Grants Summary Judgment in $200 Million FCA Case
April 1, 2016| Blog| Viewpoint

Craft Glue
April 1, 2016| News
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
